Jason Carte

Title: Jason Carte: Innovator in CRISPR Technology

Introduction

Jason Carte is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of genetic engineering, particularly through his work on CRISPR technology. His innovative approach has led to advancements in the manipulation of nucleic acids, which has far-reaching implications in biotechnology and medicine.

Latest Patents

Jason Carte holds 1 patent for his groundbreaking work on CRISPR DNA and RNA targeting enzymes and systems. This patent describes novel systems, methods, and compositions for the targeted manipulation of nucleic acids. The disclosure details non-naturally occurring, engineered CRISPR systems, components, and methods for the targeted modification of nucleic acids such as DNA. Each system includes one or more protein components and one or more nucleic acid components that work together to target nucleic acids effectively.

Career Highlights

Jason Carte is currently employed at Arbor Biotechnologies, Inc., where he continues to push the boundaries of genetic research. His work has positioned him as a key figure in the development of CRISPR technologies, which are revolutionizing the field of genetics.

Collaborations

Jason collaborates with talented individuals in his field, including Elise Keston-Smith and David Arthur Scott. These partnerships enhance the innovative environment at Arbor Biotechnologies, Inc. and contribute to the advancement of CRISPR technology.

Conclusion

In summary, Jason Carte is a leading inventor in the realm of CRISPR technology, with a focus on targeted manipulation of nucleic acids. His contributions are paving the way for future advancements in genetic engineering and biotechnology.